Skip to main content

Smiths is an intrinsically strong company with many strengths, and our businesses are well positioned for the future – leading positions in attractive markets, world-class engineering expertise, differentiated proprietary technology, strong brands and talented people united by a purpose-led, innovative and continuous improvement culture.

Explore our business model Arrow right icon
Roland Carter
Quote mark left

We are making good strategic, operational and financial progress, and all our businesses are well positioned for compelling value creation.

Roland Carter
Smiths Group CEO

Smiths Group plc investment highlights

In FY24 we made significant progress against our medium-term targets

+5.4%

Organic revenue growth

+8.3%

Headline EPS growth

16.4%

ROCE

16.8%

Headline operating profit margin

97%

Headline operating cash conversion

Detection Engineer Landscape

Fundamentally strong business

Smiths is a FTSE 100 company with a balanced portfolio of market-leading, industrial technology businesses. All our businesses have leading positions in critical markets, and deliver superior customer service through our global capabilities and sustained investment in R&D. 

All of this supported by a robust financial framework with high proportion of recurring revenues through our aftermarket offering, and high and resilient margins. 

Explore our business model Arrow right icon
Best Investor Communications Award 2023 Logo

Recognition

Our team were delighted to have been recognised at the UK PLC awards ceremony winning the Best Investor Communications award. As part of the submission we were recognised for our strong corporate website, innovative approach to capital market events and our ESG communications.

Tackling critical issues

Global megatrends are reshaping our lives. Climate change, safety and security, and insatiable demand for data are some of the most pressing challenges facing human society in the next few decades. Explore how we’re using our engineering expertise to tackle these critical global opportunities and improve our world.

Growth

Building momentum

In FY2024 we delivered further progress, with organic revenue growth of +5.4% and a +30bps increase in headline operating profit margin to 16.8%, both in line with guidance, and headline earnings per share growth of +8.3%. We improved headline operating cash conversion to 97% through a focus on working capital. We have announced two highly attractive acquisitions, deploying capital in a disciplined way whilst maintaining our strong balance sheet. We are well set for continued delivery in FY2025, and beyond. Effective execution of our strategy has enhanced our performance, but there is more we can do – and we will build on, and out from, this solid foundation.

Latest financial results Call to action arrow icon
Growth

Strong balance sheet

We have a strong balance sheet and the flexibility to support a range of growth opportunities, and will continue to allocate capital in a disciplined way for value creation. Here, organic investment (R&D and capex) will remain our primary focus, followed by strategic and disciplined M&A, and then returning excess capital to shareholders through our progressive dividend and, when compelling, share buybacks. 

As evidenced by our recent acquisitions, we have a more active acquisition pipeline than historically, providing us with a greater set of opportunities through which we can grow our businesses, while maintaining our strict value creation discipline.

Latest financial results Call to action arrow icon
Growth

Long term growth potential

Smiths has a clear strategy to deliver consistent and sustainable organic revenue growth and improved execution, and has demonstrated significant progress against this in recent years. Effective execution of our strategy has enhanced our performance, but there is more we can do – and we will build on, and out from, this solid foundation.

We see significant long-term growth potential at Smiths.

Business strategy Call to action arrow icon

Total shareholder return